75 filings
ARS
2023 FY
PRME
Prime Medicine Inc
29 Apr 24
Annual report to shareholders
4:08pm
DEFA14A
PRME
Prime Medicine Inc
29 Apr 24
Additional proxy soliciting materials
4:05pm
DEF 14A
PRME
Prime Medicine Inc
Definitive proxy
29 Apr 24
4:03pm
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
S-8
PRME
Prime Medicine Inc
1 Mar 24
Registration of securities for employees
8:09am
8-K
cbw29br7
1 Mar 24
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
8:01am
8-K
3wdm55gs4a1 7t0j8fs
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
424B5
qyb8cjj 5rsw4
16 Feb 24
Prospectus supplement for primary offering
6:17am
FWP
i5wn86s
14 Feb 24
Free writing prospectus
9:57pm
424B5
qq9rq
14 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
cmy9 urqn2x
14 Feb 24
Results of Operations and Financial Condition
4:12pm
8-K
v88eboqr7 mwlplm6hw
8 Jan 24
Regulation FD Disclosure
8:01am
8-K
rjh6pby
5 Jan 24
Other Events
5:03pm
8-K
sqxkm g94qc1jj9sv
5 Jan 24
Departure of Directors or Certain Officers
8:15am
EFFECT
bfpole
14 Nov 23
Notice of effectiveness
12:15am
CORRESP
waai2mwyrhgf7hl
9 Nov 23
Correspondence with SEC
12:00am
UPLOAD
u00nfoz2
7 Nov 23
Letter from SEC
12:00am
S-3
csemo6bn5
3 Nov 23
Shelf registration
5:23pm